The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
118954502 11895450 2 F 20151215 20160107 20160926 PER PHEH2015US026819 NOVARTIS 38.00 YR F Y 0.00000 20160926 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
118954502 11895450 1 PS GLEEVEC IMATINIB MESYLATE 1 Unknown UNK U 21588

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
118954502 11895450 1 Chronic myeloid leukaemia

Outcome of event

no results found

Reactions reported

Event ID CASEID DRUG REC ACT PT
118954502 11895450 Alopecia
118954502 11895450 Anxiety
118954502 11895450 Arthralgia
118954502 11895450 Asthenopia
118954502 11895450 Bone pain
118954502 11895450 Cognitive disorder
118954502 11895450 Confusional state
118954502 11895450 Constipation
118954502 11895450 Decreased appetite
118954502 11895450 Diarrhoea
118954502 11895450 Disturbance in attention
118954502 11895450 Dizziness
118954502 11895450 Fatigue
118954502 11895450 Hepatic steatosis
118954502 11895450 Hyperhidrosis
118954502 11895450 Hypoaesthesia
118954502 11895450 Insomnia
118954502 11895450 Libido decreased
118954502 11895450 Muscle spasms
118954502 11895450 Muscular weakness
118954502 11895450 Nausea
118954502 11895450 Oedema
118954502 11895450 Pallor
118954502 11895450 Pruritus
118954502 11895450 Rash
118954502 11895450 Vision blurred
118954502 11895450 Vomiting
118954502 11895450 Weight increased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found